AbilTo, Inc., a New York-based provider of behavioral change programs to improve medical health and lower cost, closed a $12m Series C round of financing.
The round was led by HLM Venture Partners (HLM) with participation from previous investors BlueCross BlueShield Venture Partners, .406 Ventures and Sandbox Industries. In conjunction with the funding, Yumin Choi, Partner, HLM, joined AbilTo’s board of directors.
The company intends to use the funds to accelerate the deployment of engagement, care delivery and infrastructure capabilities.
Founded in 2008 by Michael Laskoff, CEO, AbilTo leverages emerging technology to provide health plans and plan sponsors with the opportunity to provide patient engagement with behavior change treatment programs for large medical populations, including cardiac patients, new mothers and those suffering from diabetes, as well as individuals suffering from depression/anxiety and chronic pain.
The company currently offers 16 programs – delivered by telephone or the Internet.